Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00367978 · ClinicalTrials.gov registry record · Phase 4
Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus
A Phase 4 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 4
- Development phase
- 275
- Enrollment target
NCT00367978 is a Phase 4 study that has completed, run by Novartis. The registered enrollment target is 275 participants.
The verdict
NCT00367978, a Phase 4 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 275 participants
- Enrollment target
Study Summary
This study evaluated the efficacy and safety of amlodipine/benazepril compared with that of enalapril in the treatment of hypertension in African-American patients with type 2 diabetes.
Interventions
- DRUG Amlodipine/benazepril
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2001-12 |
| Est. Completion | 2003-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00367978
The ClinicalTrials.gov registry entry for NCT00367978 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Amlodipine/benazepril is the first listed.
NCT00367978 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00367978 about?
NCT00367978 is a clinical study titled "Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus". This study evaluated the efficacy and safety of amlodipine/benazepril compared with that of enalapril in the treatment of hypertension in African-American patients with type 2 diabetes.
What is the current status of trial NCT00367978?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 275 participants. The study started on 2001-12. Estimated completion is 2003-09.
What interventions are being tested in trial NCT00367978?
The interventions under investigation include: Amlodipine/benazepril (DRUG).
Who is sponsoring clinical trial NCT00367978?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.